Literature DB >> 356525

[Immunfluorescence of human brain tumours (author's transl)].

D K Böker.   

Abstract

Sera of 38 patients with various intracranial tumours were examined by indirect immunofluorescence for antibodies against their own tumours. The frequency of antibodies found in this investigation corresponds to the frequency of antibodies against tumours of other organs. Antibodies were found in 9 out of 14 glioblastomas, in 3 out of 10 slower growing gliomas, and in 2 sarcomas. Antibodies could not be demonstrated in metastases, meningiomas, or Lindau tumours. Localization of antigens by immunofluorescnece suggests that they are surface antigens. Antibodies are found in sera collected two days after surgery as well as in sera obtained two weeks after surgery. The method used did not demonstrate any complement dependency. Possibilities for diagnostic use are discussed.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 356525     DOI: 10.1007/bf01811349

Source DB:  PubMed          Journal:  Acta Neurochir (Wien)        ISSN: 0001-6268            Impact factor:   2.216


  17 in total

1.  STUDIES IN IMMUNIZATION AGAINST A TRANSPLANTABLE CEREBRAL MOUSE GLIOMA.

Authors:  L C SCHEINBERG; K SUZUKI; F EDELMAN; L M DAVIDOFF
Journal:  J Neurosurg       Date:  1963-04       Impact factor: 5.115

2.  Autoradiographic and fluorescence antibody studies of the human host immune response to gliomas.

Authors:  A E Eggers
Journal:  Neurology       Date:  1972-03       Impact factor: 9.910

3.  In vitro demonstration of cell-mediated immunity to human brain tumors.

Authors:  N L Levy; M S Mahaley; E D Day
Journal:  Cancer Res       Date:  1972-03       Impact factor: 12.701

4.  Tissue culture study of glioblastoma cells with addition of autologous lymphocytes.

Authors:  J Ciembroniewicz; O Kolar
Journal:  Acta Cytol       Date:  1969-01       Impact factor: 2.319

5.  Detection by immunofluorescence of antibodies specific for human malignant melanoma cells.

Authors:  N M Muna; S Marcus; C Smart
Journal:  Cancer       Date:  1969-01       Impact factor: 6.860

6.  Suspension culture of a pigment-producing cell line derived from a human malignant melanoma.

Authors:  H F Oettgen; T Aoki; L J Old; E A Boyse; E de Harven; G M Mills
Journal:  J Natl Cancer Inst       Date:  1968-10       Impact factor: 13.506

7.  Cellular and humoral immune responses to human urinary bladder carcinomas.

Authors:  J Bubeník; P Perlmann; K Helmstein; G Moberger
Journal:  Int J Cancer       Date:  1970-05-15       Impact factor: 7.396

8.  Immunological studies with human gliomas.

Authors:  M S Mahaley
Journal:  J Neurosurg       Date:  1971-03       Impact factor: 5.115

9.  Cellular and humoral immunity against human malignant melanoma.

Authors:  G Fossati; M I Colnaghi; G D Porta; N Cascinelli; U Veronesi
Journal:  Int J Cancer       Date:  1971-09-15       Impact factor: 7.396

10.  Depressed cell-mediated immunity in patients with primary intracranial tumors. Characterization of a humoral immunosuppressive factor.

Authors:  W H Brooks; M G Netsky; D E Normansell; D A Horwitz
Journal:  J Exp Med       Date:  1972-12-01       Impact factor: 14.307

View more
  2 in total

Review 1.  Immunobiologic aspects of the brain and human gliomas. A review.

Authors:  C J Wikstrand; D D Bigner
Journal:  Am J Pathol       Date:  1980-02       Impact factor: 4.307

2.  The utilization of native glioma antigens in the assessment of cellular and humoral immune responses in malignant glioma patients.

Authors:  M L Apuzzo; K M Sheikh; M H Weiss; J S Heiden; T Kurze
Journal:  Acta Neurochir (Wien)       Date:  1981       Impact factor: 2.216

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.